Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
| dc.contributor.author | Abraham, SA | en_US |
| dc.contributor.author | Hopcroft, LEM | en_US |
| dc.contributor.author | Carrick, E | en_US |
| dc.contributor.author | Drotar, ME | en_US |
| dc.contributor.author | Dunn, K | en_US |
| dc.contributor.author | Williamson, AJK | en_US |
| dc.contributor.author | Korfi, K | en_US |
| dc.contributor.author | Baquero, P | en_US |
| dc.contributor.author | Park, LE | en_US |
| dc.contributor.author | Scott, MT | en_US |
| dc.contributor.author | Pellicano, F | en_US |
| dc.contributor.author | Pierce, A | en_US |
| dc.contributor.author | Copland, M | en_US |
| dc.contributor.author | Nourse, C | en_US |
| dc.contributor.author | Grimmond, SM | en_US |
| dc.contributor.author | Vetrie, D | en_US |
| dc.contributor.author | Whetton, AD | en_US |
| dc.contributor.author | Holyoake, TL | en_US |
| dc.date.accessioned | 2017-01-31T15:59:33Z | |
| dc.date.available | 2016-04-26 | en_US |
| dc.date.issued | 2016-06-16 | en_US |
| dc.date.submitted | 2017-01-30T10:46:59.319Z | |
| dc.identifier.issn | 0028-0836 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/19092 | |
| dc.description.sponsorship | e Glasgow and Manchester Experimental Cancer Medicine Centres (ECMC), which are funded by CR-UK and the Chief Scientist’s Office (Scotland). We acknowledge the funders who have contributed to this work: MRC stratified medicine infrastructure award (A.D.W.), CR-UK C11074/A11008 (F.P., L.E.M.H., T.L.H., A.D.W.); LLR08071 (S.A.A., E.C.); LLR11017 (M.C.); SCD/04 (M.C.); LLR13035 (S.A.A., K.D., A.D.W., and A.P.); LLR14005 (M.T.S., D.V.); KKL690 (L.E.P.); KKL698 (P.B.); LLR08004 (A.D.W., A.P. and A.J.W.); MRC CiC (M.E.D.); The Howat Foundation (FACS support); Friends of Paul O’Gorman (K.D. and FACS support); ELF 67954 (S.A.A.); BSH start up fund (S.A.A.); MR/K014854/1 (K.D.). | en_US |
| dc.format.extent | 341 - + | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | NATURE | en_US |
| dc.title | Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1038/nature18288 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000377856800026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 7607 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 534 | en_US |
